Terms: = Lung cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Diagnosis
261 results:
1. Tumor-derived exosomal PD-L1: a new perspective in pd-1/PD-L1 therapy for lung cancer.
Wu Y; Fu H; Hao J; Yang Z; Qiao X; Li Y; Zhao R; Lin T; Wang Y; Wang M
Front Immunol; 2024; 15():1342728. PubMed ID: 38562933
[TBL] [Abstract] [Full Text] [Related]
2. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
[TBL] [Abstract] [Full Text] [Related]
3. An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury.
Riveiro-Barciela M; Barreira-Díaz A; Salcedo MT; Callejo-Pérez A; Muñoz-Couselo E; Iranzo P; Ortiz-Velez C; Cedrés S; Díaz-Mejía N; Ruiz-Cobo JC; Morales R; Aguilar-Company J; Zamora E; Oliveira M; Sanz-Martínez MT; Viladomiu L; Martínez-Gallo M; Felip E; Buti M
Aliment Pharmacol Ther; 2024 Apr; 59(7):865-876. PubMed ID: 38327102
[TBL] [Abstract] [Full Text] [Related]
4. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract] [Full Text] [Related]
5. Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Bafaloukos D; Kouzis P; Gouveris P; Boukovinas I; Kalbakis K; Baka S; Kyriakakis G; Moschou D; Molfeta A; Demiri S; Mavroudis D; Spanoudi F; Dimitriadis I; Gogas H
Melanoma Res; 2024 Apr; 34(2):152-165. PubMed ID: 38092014
[TBL] [Abstract] [Full Text] [Related]
6. Anti-pd1 does not improve pyroptosis induced by γδ T cells but promotes tumor regression in a pleural mesothelioma mouse model.
Lui KS; Ye Z; Chan HC; Tanaka Y; Cheung AKL
Front Immunol; 2023; 14():1282710. PubMed ID: 38077396
[TBL] [Abstract] [Full Text] [Related]
7. Pulmonary pleomorphic carcinoma treated with pd-1 inhibitor: Two case reports.
Jiang T; Wang H; Xue F; Wu X; Ni M; Wang Y; Chen N; Zhang Y; Zhang G; Fu J; Liu X; Wu Q
Thorac Cancer; 2023 Nov; 14(32):3240-3244. PubMed ID: 37779217
[TBL] [Abstract] [Full Text] [Related]
8. Significant response to transarterial chemoembolization combined with pd-1 inhibitor and apatinib for advanced intrahepatic cholangiocarcinoma: A case report and literature review.
Zhang H; Han C; Zheng X; Zhao W; Liu Y; Ye X
J Cancer Res Ther; 2023 Aug; 19(4):1055-1060. PubMed ID: 37675736
[TBL] [Abstract] [Full Text] [Related]
9. [Exploration of the Perturbation of PKIG in lung Squamous Cell Carcinoma and the Role in Tumor Microenvironment Based on Bioinformatics Method].
Liu Q; Li H; Li B; Ren M; Li Z; Chen Y; Zheng Z; Meng Y; Feng H
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):523-537. PubMed ID: 37653016
[TBL] [Abstract] [Full Text] [Related]
10. Smoking Status at Time of diagnosis Affects the Efficacy of Anti-pd-1/L1 Therapy in Patients With Advanced NSCLC.
Kim KY; Lim JU; Kang HS; Kim JS; Kim SK; Kim SJ; Lee SH; Yeo CD
In Vivo; 2023; 37(5):2357-2364. PubMed ID: 37652510
[TBL] [Abstract] [Full Text] [Related]
11. diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors.
Wang J; Elghawy O; Kurpiel B; Kaur V
Clin J Gastroenterol; 2023 Dec; 16(6):807-814. PubMed ID: 37651059
[TBL] [Abstract] [Full Text] [Related]
12. Simultaneous Presentation of Secondary Adrenal Insufficiency and Primary Hypothyroidism due to Pembrolizumab: A Case Report.
Khatri S; Alom M; Kashfi S; Atallah J; Goswami G
J Investig Med High Impact Case Rep; 2023; 11():23247096231194401. PubMed ID: 37642143
[TBL] [Abstract] [Full Text] [Related]
13. Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with brain metastases.
Yan X; Qu F; Zhou Y
Lung Cancer; 2023 Oct; 184():107322. PubMed ID: 37611495
[TBL] [Abstract] [Full Text] [Related]
14. Pulmonary sarcoidosis-like reactions induced by sintilimab in esophageal cancer: A case report.
Li H; Mu F; Zou B; Wang L
Medicine (Baltimore); 2023 Aug; 102(31):e34432. PubMed ID: 37543824
[TBL] [Abstract] [Full Text] [Related]
15. The Implication of Liquid Biopsy in the Non-small Cell lung cancer: Potential and Expectation.
Ren J; Liu R
Methods Mol Biol; 2023; 2695():145-163. PubMed ID: 37450117
[TBL] [Abstract] [Full Text] [Related]
16. Immune checkpoint inhibitor-related chronic pneumonitis: a case report and literature review.
Yuan-Di Wang ; Yuan S; Wen C; Ji Z; Xiang B; Wang B; Zhang Z
Immunotherapy; 2023 Oct; 15(14):1117-1123. PubMed ID: 37431609
[TBL] [Abstract] [Full Text] [Related]
17. Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors.
Nelli F; Giannarelli D; Fabbri A; Virtuoso A; Giron Berrios JR; Marrucci E; Fiore C; Schirripa M; Signorelli C; Chilelli MG; Primi F; Panichi V; Topini G; Silvestri MA; Ruggeri EM
Cancer Immunol Immunother; 2023 Oct; 72(10):3217-3228. PubMed ID: 37428196
[TBL] [Abstract] [Full Text] [Related]
18. Lessons from the diagnosis and treatment of severe immune checkpoint inhibitor-associated pneumonia: a case report.
Weng F; Wei J; Sang M; Gao X; Zhang P; Fu Q
Immunotherapy; 2023 Aug; 15(12):897-903. PubMed ID: 37337737
[TBL] [Abstract] [Full Text] [Related]
19. Traditional Treatment Approaches and Role of Immunotherapy in lung Malignancy and Mesothelioma.
Tamanna MT; Egbune C
Cancer Treat Res; 2023; 185():79-89. PubMed ID: 37306905
[TBL] [Abstract] [Full Text] [Related]
20. B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma.
Cui Y; Li J; Zhang P; Yin D; Wang Z; Dai J; Wang W; Zhang E; Guo R
J Exp Clin Cancer Res; 2023 Jun; 42(1):146. PubMed ID: 37303063
[TBL] [Abstract] [Full Text] [Related]
[Next]
